BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 101-120 of 203 (Search time: 0.008 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1012009Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancerBUYSE, MarcJournal ContributionA1
1022009Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient dataMichiels, Stefan; Le Maitre, Aurelie; BUYSE, Marc; BURZYKOWSKI, Tomasz; Maillard, Emilie; Bogaerts, Jan; Vermorken, Jan B.; Budach, Wilfried; Pajak, Thomas F.; Ang, Kian K.; Bourhis, Jean; Pignon, Jean-PierreJournal ContributionA1
1032009Use of Meta-Analysis for the Validation of Surrogate Endpoints and Biomarkers in Cancer TrialsBUYSE, MarcJournal ContributionA1
1042008European regulatory agencies should employ full time statisticiansHughes, Sara; Keene, Oliver; Howitt, Nigel; Roes, Kit; Ashby, Deborah; Beltangady, Mohan; Bird, Sheila M.; Burton, Catherine; BUYSE, Marc; Day, Simon; van Ewijk, Peter; Fletcher, Chrissie; Grieve, Andrew P.; Guinot, Christiane; Hand, David J.; Hemmings, Rob; Holt, D.; Hothorn, Ludwig; Jagers, Peter; Keiding, Niels; Korhonen, Pasi; LESAFFRE, Emmanuel; Lewis, John A.; MOLENBERGHS, Geert; Neumann, Norbert; Olsen, Klaus Juel; van Osta, Gonnie; Pocock, Stuart; Rockhold, Frank; Rossi, Andrea; Senn, Stephen; Stijnen, Theo; Vaeth, Michael; Wiklund, Stig Johan; Wolfram, JosephineJournal ContributionA1
1052008Ensuring trial validity by data quality assurance and diversification of monitoring methodsBaigent, C.; Harrell, F.; BUYSE, Marc; Emberson, J.; Altman, D.Proceedings PaperC1
1062008Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission.BUYSE, Marc; Squifflet, Pierre; Rowe, Jacob M.; Whisnant, John K.; Bhagwat, Dileep; Allard, Stephane E.; Hellstrand, Kristoffer; Brune, Mats L.Journal ContributionM
1072008Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancerBURZYKOWSKI, Tomasz; BUYSE, Marc; Piccart-Gebhart, Martine J.; Sledge, George; Carmichael, James; Lueck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
1082008The meta-analytic framework for the evaluation of surrogate endpoints in clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; BUYSE, MarcJournal ContributionA1
1092008Exploring and validating surrogate endpoints in colorectal cancerBURZYKOWSKI, Tomasz; BUYSE, Marc; Yothers, Greg; Sakamoto, Junichi; Sargent, DanJournal ContributionA1
1102008Endpoints and surrogate endpoints in colorectal cancer: a review of recent developmentsPIEDBOIS, P.; BUYSE, MarcJournal ContributionA1
1112008Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerPiccart-Gebhart, Martine J.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sledge, George; Carmichael, James; Luck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
1122008Individual- and trial-level surrogacy in colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Michiels, Stefan; Carroll, KevinJournal ContributionA1
1132008Reformulating the hazard ratio to enhance communication with clinical investigatorsBUYSE, MarcJournal ContributionA1
1142007Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!Collette, Laurence; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
1152007Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerde Gramont, Aimery; BUYSE, Marc; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Cervantes, Andres; Figer, Arie; Lledo, Gerard; Flesch, Michel; Mineur, Laurent; Carola, Elisabeth; Etienne, Pierre-Luc; Rivera, Fernando; Chirivella, Isabel; Perez-Staub, Nathalie; Louvet, Christophe; André, Thierry; Tabah-Fisch, Isabelle; Tournigand, ChristopheJournal ContributionA1
1162007Progression-free survival is a surrogate for survival in advanced colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, Kevin; Michiels, Stefan; Sargent, Daniel J.; Miller, Langdon L.; Elfring, Gary L.; Pignon, Jean-Pierre; Piedbois, PascalJournal ContributionA1
1172006Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trialBogaerts, J.; Cardoso, F.; BUYSE, Marc; Braga, S.; Loi, S.; Harrison, J. A.; Bines, J.; Mook, S.; Decker, N.; Ravdin, P.; Therasse, P.; Rutgers, E.; van't Veer, L. J.; Piccart, M.Journal ContributionA1
1182006Alternative clinical end points in rectal cancer—are we getting closer?Glynne-Jones, R; Mawdsley, S; Pearce, T; BUYSE, MarcJournal ContributionA1
1192006Analysis of oxaliplatin reintroduction in patients with advanced colorectal cancer (CRC) treated with FOLFOX4 or FOLFOX7 in the optimox studyBUYSE, Marc; Quinaux, E; CORTINAS ABRAHANTES, Jose; Tournigand, C; Cervantes, A; Figer, A; André, Thierry; Tabah-Fisch, I; De Gramont, AJournal ContributionM
1202006Current issues in adjuvant treatment of stage II colon cancerAndré, Thierry; Sargent, D; Tabernero, J; O'Connell, M; BUYSE, Marc; Sobrero, A; Misset, J.L.; Boni, C; de Gramont, AJournal ContributionA1
show all